Depression is one of the most common comorbidities of many chronic medical diseases
including cancer and cardiovascular, metabolic, inflammatory and neurological disorders …

Background In patients with heart failure (HF), depression and anxiety disorders are
common and associated with adverse outcomes such as reduced adherence to treatment …

Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment
for major depressive disorders and are considered to be safer than tricyclic agents. In this …

People with severe mental illness have a considerably shorter lifespan than the general
population. This excess mortality is mainly due to physical illness. Next to mental illness …

Randomized trials have shown that selective serotonin reuptake inhibitors (SSRIs) and
serotonin-norepinephrine reuptake inhibitors (SNRIs) have better safety profiles than …

Anxiety and its associated disorders are common in patients with cardiovascular disease
and may significantly influence cardiac health. Anxiety disorders are associated with the …

Introduction: Generalized anxiety disorder (GAD) often begins during adolescence or early
adulthood and persists throughout the lifespan. Randomized controlled trials support the …

Populations with common physical diseases–such as cardiovascular diseases, cancer and
neurodegenerative disorders–experience substantially higher rates of major depressive …

Although resilience and high quality of life are demonstrated by many individuals with
congenital heart disease, a range of significant psychological challenges exists across the …

Background Some psychotropic medications have been associated with prolongation of the
QT interval and QT prolongation, especially in those with medical illness, and are linked to …